Effect of formulation ingredients on the physical characteristics of salmeterol xinafoate microparticles tailored by spray freeze drying

Series of microparticles containing salmeterol xinafoate (SX) as active pharmaceutical ingredient (API) and lactose, mannitol or trehalose as a bulking agents were prepared using spray freeze drying (SFD) technique and the effects of sugar type and presence of hydroxy propyl beta cyclodextrin (HPβCD) on the physical properties of powders were evaluated. Precipitation of salmeterol in the presence of lactose and mannitol resulted in the formation of irregular shapes of microparticles with broad size distributions. However application of trehalose resulted in the formation of porous particles with spherical morphology. Addition of cyclodextrin in the formulations was generally helpful for formation of porous and spherical particles with narrow size distribution with a mean size of 10–30 μm. Dissolution of SX from processed particles was substantially higher (∼90% drug release in 30 min) than that of unprocessed drug and physical mixture of drug and cyclodextrin (∼22% drug release in 30 min). This study showed that, processing of SX by SFD technique could be a constructive approach to the production of various forms of drug and drastic changes in the physical characteristics of microparticles could be achieved by changing the composition of bulking agent and cyclodextrin.

Figure optionsDownload as PowerPoint slideHighlights
► Spray freeze drying (SFD) could produce tailored particles containing salmeterol xinafoate (SX).
► Physical characteristics of SX microparticles was affected by formulation variables.
► HPβCD could improve the physical appearance of microparticles containing SX.
► The presence of HPβCD in SFD processed particles enhanced dissolution rate of SX.